Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Role of Diacylglycerol Kinase Epsilon (DGKE) in Atypical Hemolytic Uremic Syndrome (aHUS) and Endothelial Cell Dysfunction
FY 2016-17
Summary
Blood vessels provide a pathway for the exchange of nutrients and wastes in our bodies. When blood vessels are damaged, blockages are created in the vessel. These blockages promote repair and prevent further damage. However, excessive blood vessel blockage, known as thrombosis, can lead to complications. We aim to study the role of cells that make up blood vessels, known as endothelial cells. Specifically, we want to study how endothelial cells regulate thrombosis. Abnormal function of a protein named DGKE (diacylglycerol kinase epsilon) leads to a rare kidney disorder, known as aHUS (atypical hemolytic uremic syndrome). Patients with aHUS have excessive blockages in kidney blood vessels. These patients often progress to kidney failure and require a kidney transplant. There are no treatment for this disease. DGKE converts a fat, known as DAG (diacylglycerol) into another type of fat, known as PA (phosphatidic acid). DAG and PA are used to regenerate other fats.We hypothesize that DGKE dysfunction causes abnormally low levels of lipids that play key roles in endothelial cells, which may result in thrombosis. Using various cutting edge techniques, we aim to study how DGKE in endothelial cells normally help prevents thrombosis. By doing so, we hope to understand how endothelial cell fats regulate thrombosis. These data will drive the design new therapies for patients with DGKE aHUS. It will also help provide a better understanding of how endothelial cells prevent thrombosis.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367334
Name
So Vincent
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of Diacylglycerol Kinase Epsilon (DGKE) in Atypical Hemolytic Uremic Syndrome (aHUS) and Endothelial Cell Dysfunction
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
5-Bisphosphate; Atypical Hemolytic Uremic Syndrome (Ahus); Diacylglycerol Kinase Epsilon; Endothelial Cells; Glomerular Injury; Lipid Synthesis; Nephropathy; Phosphatidylinositol 4; Phosphatidylinositol Cycle; Rare Kidney Disorders; Thrombotic Microangiopathy
Abstract
Blood vessels provide a pathway for the exchange of nutrients and wastes in our bodies. When blood vessels are damaged, blockages are created in the vessel. These blockages promote repair and prevent further damage. However, excessive blood vessel blockage, known as thrombosis, can lead to complications. We aim to study the role of cells that make up blood vessels, known as endothelial cells. Specifically, we want to study how endothelial cells regulate thrombosis. Abnormal function of a protein named DGKE (diacylglycerol kinase epsilon) leads to a rare kidney disorder, known as aHUS (atypical hemolytic uremic syndrome). Patients with aHUS have excessive blockages in kidney blood vessels. These patients often progress to kidney failure and require a kidney transplant. There are no treatment for this disease. DGKE converts a fat, known as DAG (diacylglycerol) into another type of fat, known as PA (phosphatidic acid). DAG and PA are used to regenerate other fats.We hypothesize that DGKE dysfunction causes abnormally low levels of lipids that play key roles in endothelial cells, which may result in thrombosis. Using various cutting edge techniques, we aim to study how DGKE in endothelial cells normally help prevents thrombosis. By doing so, we hope to understand how endothelial cell fats regulate thrombosis. These data will drive the design new therapies for patients with DGKE aHUS. It will also help provide a better understanding of how endothelial cells prevent thrombosis.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
So, Vincent
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~